Xilio Therapeutics
31 hedge funds and large institutions have $13.4M invested in Xilio Therapeutics in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$366K | |
| 2 | +$43K | |
| 3 | +$42.9K | |
| 4 |
SFG
SevenBridge Financial Group
Harrisburg,
Pennsylvania
|
+$36.6K |
| 5 |
PI
PFG Investments
Woodbury,
New York
|
+$32.4K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$982K | |
| 3 | -$248K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$91.2K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$64.3K |